Colgate-Palmolive Company
NYSE:CLHousehold & Personal Products
-$0.71 today
- Market cap
- $78.58B
- Beta
- 0.32
- P/E (TTM)
- 34.5
- EPS (TTM)
- $2.60
- Dividend yield
- 2.33%
Volume 6.07M
Average 5.62M
CL Effect of Forex Changes
Change in reported cash caused by exchange-rate movements on foreign-currency balances.
Colgate-Palmolive CompanyNYSE: CL
Effect of Forex Changes · Q3 FY2026 · quarter ended Sep 2026
Effect of forex changes growth accelerates
Q3 FY2026 effect of forex changes of $19M (cash outflow) rose 26.7% year over year, ahead of the +0.0% change in trailing-twelve-month effect of forex changes.
Context
- Effect of forex changes amounted to 0.3% of revenue in FY2025, unchanged from a year earlier.
- Effect of forex changes increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +26.7% holds above the trailing-twelve-month pace of +0.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Effect of Forex Changes history
USD · from the cash flow
- Latest · FY2025
- 67M USD
- Year-over-year change
- +224.1%
| Period | Period end | Effect of Forex Changes | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 67M | +224.1% |
| FY2024 | 2024-12-31 | (54M) | -184.2% |
| FY2023 | 2023-12-31 | (19M) | +68.3% |
| FY2022 | 2022-12-31 | (60M) | -300.0% |
| FY2021 | 2021-12-31 | (15M) | — |
Effect of Forex Changes vs competitors
How CL compares with its peers on the latest reported figures
- Peers report in different currencies, so effect of forex changes is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +0.0% is the 5th highest of 7, against a peer median of +55.2%.
- Effect of forex changes amounts to 0.0% of revenue for CL, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | €498M EUR | +937.5% | +314.4% | 1.0% | |
| LTM Sep 2026 | $95M USD | +295.8% | -20.3% | 0.1% | |
| LTM Jun 2026 | $16M USD | -277.8% | +75.0% | 0.1% | |
| LTM Sep 2026 | $5M USD | +66.7% | — | 0.1% | |
| LTM Sep 2026 | $2.3M USD | +43.8% | — | 0.0% | |
| LTM Sep 2026 | $2M USD | -66.7% | — | 0.0% | |
| LTM Sep 2026 | $1M USD | +0.0% | — | 0.0% | |
| Peer median (excluding CL) | — | +55.2% | +75.0% | 0.1% | |
Competitors are the stored peer set for CL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.34B | 1.97B | 2.46B | 3.05B | 2.13B |
| Depreciation & Amortization | 556M | 545M | 567M | 605M | 630M |
| Deferred Income Tax | (132M) | (78M) | (98M) | (77M) | (109M) |
| Stock-Based Compensation | 135M | 125M | 122M | 135M | 0 |
| Change in Working Capital | (197M) | (726M) | 455M | 344M | 284M |
| Accounts Receivables | (84M) | (227M) | (37M) | (56M) | (16M) |
| Inventory | (72M) | (333M) | 194M | (100M) | 109M |
| Accounts Payables | 0 | 0 | 0 | 516M | 251M |
| Other Working Capital | (41M) | (166M) | 298M | (16M) | (60M) |
| Other Non-Cash Items | 625M | 723M | 244M | 51M | 1.26B |
| Operating Cash Flow | 3.33B | 2.56B | 3.75B | 4.11B | 4.2B |
| Capital Expenditures | (567M) | (696M) | (705M) | (561M) | (564M) |
| Acquisitions (Net) | 0 | (809M) | 0 | 0 | (293M) |
| Purchases of Investments | (141M) | (470M) | (506M) | (574M) | (698M) |
| Sales of Investments | 141M | 322M | 502M | 564M | 752M |
| Other Investing Activities | (25M) | 52M | (33M) | 37M | (14M) |
| Investing Cash Flow | (592M) | (1.6B) | (742M) | (534M) | (817M) |
| Debt Repayment | (175M) | 1.65B | (314M) | (408M) | (456M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 101M |
| Common Stock Repurchased | (1.32B) | (1.31B) | (1.13B) | (1.74B) | (1.21B) |
| Dividends Paid | (1.68B) | (1.69B) | (1.75B) | (1.79B) | (1.82B) |
| Other Financing Activities | 400M | 400M | 398M | 547M | 132M |
| Financing Cash Flow | (2.77B) | (952M) | (2.79B) | (3.39B) | (3.26B) |
| Effect of Forex Changes | (15M) | (60M) | (19M) | (54M) | 67M |
| Net Change in Cash | (56M) | (57M) | 191M | 130M | 192M |
| Free Cash Flow | 2.76B | 1.86B | 3.04B | 3.55B | 3.63B |
Colgate-Palmolive Company
NYSE:CL
Intrinsic Alpha fair value
Locked
Current Price
$98.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.